Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...

The Faculty of Medicine at Imperial is a world-class teaching, learning and research environment ...